Home
Guide
Picks
High Yield
Dates
Monthly
Screener
Resources
ESG
Retire
Channels
Continue to site >
Trending ETFs
You take care of your investments. We like that.
Upgrade to Premium to access your Watchlist and more.
Or Login to Your Premium Account

ProShares UltraShort Nasdaq Biotechnology

ETF
BIS
Payout Change
Pending
Price as of:
$15.5 -0.04 -0.26%
primary theme
Inverse Equity
BIS (ETF)

ProShares UltraShort Nasdaq Biotechnology

Payout Change
Pending
Price as of:
$15.5 -0.04 -0.26%
primary theme
Inverse Equity
BIS (ETF)

ProShares UltraShort Nasdaq Biotechnology

Payout Change
Pending
Price as of:
$15.5 -0.04 -0.26%
primary theme
Inverse Equity

Name

As of 11/04/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

ProShares UltraShort Nasdaq Biotechnology

BIS | ETF

$15.50

$3.26 M

3.92%

$0.61

2.42%

Vitals

YTD Return

-11.5%

1 yr return

-30.6%

3 Yr Avg Return

-3.0%

5 Yr Avg Return

-24.3%

Net Assets

$3.26 M

Holdings in Top 10

130.0%

52 WEEK LOW AND HIGH

$15.5
$14.29
$25.47

Expenses

OPERATING FEES

Expense Ratio 2.42%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A

Min Investment

Standard (Taxable)

N/A

IRA

N/A

Fund Classification

Fund Type

Exchange Traded Fund

Name

As of 11/04/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

ProShares UltraShort Nasdaq Biotechnology

BIS | ETF

$15.50

$3.26 M

3.92%

$0.61

2.42%

BIS - Profile

Distributions

  • YTD Total Return -11.5%
  • 3 Yr Annualized Total Return -3.0%
  • 5 Yr Annualized Total Return -24.3%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -1.53%
DIVIDENDS
  • Dividend Yield 3.9%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    ProShares UltraShort Nasdaq Biotechnology
  • Fund Family Name
    ProShares Trust
  • Inception Date
    Apr 08, 2010
  • Shares Outstanding
    296096
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Michael Neches

Fund Description

The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.The Index is designed to measure the performance of a set ofNasdaq-listed biotechnology and pharmaceutical companies.The Index includes companies listed on the Nasdaq Global Select Market or the Nasdaq Global Market (which include both U.S. and non-U.S. companies) that are included in the biotechnology orpharmaceuticals subsectors,according to the Industry Classification Benchmark.The biotechnology and pharmaceutical subsectors include companies engaged in research into and development of biologicalsubstances for the purposes of drug discovery and diagnostic development and manufacturersof prescription or over-the-counter drugs.Companies areselected based on market capitalization and liquidity. Selected companies are then weighted based on market capitalization. The Index’s composition and the assigned weights are reevaluated every December, with additional weight adjustments occurring in March, June, and September. The Index is constructed and maintained by Nasdaq Inc. More information about the Index can be found using the Bloomberg ticker symbol “NBI.”Under normal circumstances, the Fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the Index or in instruments with similar economic characteristics.The Fund will invest principally in the financial instruments listed below.●Derivatives — Financial instruments whose value is derived from the value of an underlying asset or rate, such as stocks, bonds, ETFs, interest rates or indexes. These derivatives principally include:○Swap Agreements — Contracts entered into primarily with major global financial institutions for a specified period ranging from a day to more than one year. In a standard swap transaction, two parties agree to exchange or “swap” payments based on the change in value of an underlying asset or benchmark. For example, two parties may agree to exchange the return (or differentials in rates of returns) earned or realized on a particular investment or instrument.●Money Market Instruments — The Fund expects that any cash balances maintained in connection with its use of derivatives will typically be held in high quality, short-term money market instruments, for example:○U.S. Treasury Bills — U.S. government securities that have initial maturities of one year or less, and are supported by the full faith and credit of the U.S. government.○Repurchase Agreements — Contracts in which a seller of securities, usually U.S. government securities or other money market instruments, agrees to buy the securities back at a specified time and price.ProShare Advisors uses a mathematical approach to investing in which it determines the type, quantity and mix of investment positions that it believes, in combination, the Fund should hold to produce daily returns consistent with the Daily Target. For these purposes a day is measured from the time of one net asset value (“NAV”) calculation to the next.The Fund seeks to remain fully invested at all times in financial instruments that, in combination, provide inverse leveraged exposure consistent with the investment objective, without regard to market conditions, trends or direction. However, the Fund may invest in or gain exposure to only a representative sample of the securities in the Index or to securities not contained in the Index or in financial instruments, with the intent of obtaining inverse leveraged exposure consistent with the investment objective.The Fund seeks to rebalance its portfolio each day so that its exposure to the Index is consistent with the Daily Target. The Index’s movements during the day will affect whether the Fund’s portfolio needs to be rebalanced. For example, if the Index has risen on a given day, net assets of the Fund should fall (assuming there were no Creation Units issued). As a result, the Fund’s exposure will need to be decreased. Conversely, if the Index has fallen on a given day, net assets of the Fund should rise (assuming there were no Creation Unit redemptions). As a result, the Fund’s exposure will need to be increased.Please see “Investment Objectives, Principal Investment Strategies and Related Risks” in the Fund’s Prospectus for additional details.
Read More

BIS - Performance

Return Ranking - Trailing

Period BIS Return Category Return Low Category Return High Rank in Category (%)
YTD -11.5% -75.9% 42.7% 36.22%
1 Yr -30.6% -83.0% 23.8% 55.12%
3 Yr -3.0%* -62.4% 6.9% 22.05%
5 Yr -24.3%* -76.2% 8.8% 55.20%
10 Yr -22.2%* -70.9% 13.2% 56.52%

* Annualized

Return Ranking - Calendar

Period BIS Return Category Return Low Category Return High Rank in Category (%)
2023 -8.0% -85.3% 15.3% 11.81%
2022 -2.1% -73.7% 116.7% 87.40%
2021 -14.7% -80.9% 94.9% 22.83%
2020 -56.1% -96.0% 153.8% 71.65%
2019 -42.0% -84.0% -9.3% 75.20%

Total Return Ranking - Trailing

Period BIS Return Category Return Low Category Return High Rank in Category (%)
YTD -11.5% -75.9% 42.7% 36.22%
1 Yr -30.6% -83.0% 23.8% 55.12%
3 Yr -3.0%* -62.4% 6.9% 22.05%
5 Yr -24.3%* -76.2% 8.8% 55.20%
10 Yr -22.2%* -70.9% 13.2% 56.52%

* Annualized

Total Return Ranking - Calendar

Period BIS Return Category Return Low Category Return High Rank in Category (%)
2023 -6.6% -84.6% 18.9% 11.81%
2022 -2.1% -73.6% 117.2% 87.40%
2021 -14.7% -80.9% 94.9% 22.83%
2020 -56.0% -95.9% 153.8% 71.65%
2019 -41.0% -83.8% -8.6% 73.60%

BIS - Holdings

Concentration Analysis

BIS Category Low Category High BIS % Rank
Net Assets 3.26 M 269 K 3.02 B 71.54%
Number of Holdings 14 4 799 34.62%
Net Assets in Top 10 4.16 M 353 K 2.88 B 65.38%
Weighting of Top 10 130.02% 37.3% 230.5% 16.92%

Top 10 Holdings

  1. U.S. Treasury Bills 46.46%
  2. Repurchase Agreement 30.60%
  3. Repurchase Agreement 23.58%
  4. Repurchase Agreement 11.77%
  5. Repurchase Agreement 9.42%
  6. Total Return Swap 5.19%
  7. Repurchase Agreement 2.35%
  8. Repurchase Agreement 1.77%
  9. Repurchase Agreement 1.18%
  10. Total Return Swap -2.30%

Asset Allocation

Weighting Return Low Return High BIS % Rank
Other 		54.19% -62.82% 156.23% 45.38%
Cash 		46.46% 0.00% 237.06% 42.31%
Stocks 		0.00% -106.26% 100.00% 51.54%
Preferred Stocks 		0.00% 0.00% 0.00% 47.69%
Convertible Bonds 		0.00% 0.00% 2.47% 52.31%
Bonds 		0.00% 0.00% 92.50% 59.23%

BIS - Expenses

Operational Fees

BIS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 2.42% 0.59% 8.36% 40.16%
Management Fee 0.75% 0.35% 1.50% 27.69%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.45% N/A

Sales Fees

BIS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.75% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

BIS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 2.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BIS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 181.00% N/A

BIS - Distributions

Dividend Yield Analysis

BIS Category Low Category High BIS % Rank
Dividend Yield 3.92% 0.00% 17.26% 81.54%

Dividend Distribution Analysis

BIS Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annual Quarterly Quarterly

Net Income Ratio Analysis

BIS Category Low Category High BIS % Rank
Net Income Ratio -1.53% -7.24% 3.75% 49.14%

Capital Gain Distribution Analysis

BIS Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

BIS - Fund Manager Analysis

Managers

Michael Neches

Start Date

Tenure

Tenure Rank

Oct 01, 2013

8.67

8.7%

Michael Neches joined ProShare Advisors in 2000, and presently serves as a Senior Portfolio Manager. He previously served as the Senior Portfolio Manager responsible for the company’s commodities desk for two years, as a Portfolio Manager and team lead, as an Associate Portfolio Manager and as a Portfolio Analyst. Mr. Neches earned a Bachelor of Science in Finance from the University of Maryland, College Park and an MBA from Georgetown University.

Tarak Davé

Start Date

Tenure

Tenure Rank

Apr 30, 2018

4.09

4.1%

Tarak Dave ProFund Advisors LLC: Portfolio Manager since March 2018, Associate Portfolio Manager from November 2015 to March 2018, Senior Portfolio Analyst from May 2014 to October 2015 and Portfolio Analyst from April 2011 to April 2014.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.16 23.76 9.04 14.22

Advertisement

×

Wait! Rates are rising, is your portfolio ready?

×